---
schema_version: "secwatch.filing_event.v1"
accession: "0001185185-22-001458"
form_type: "8-K"
ticker: "IGC"
cik: "0001326205"
company_name: "IGC Pharma, Inc."
filed_at: "2022-12-29T23:59:59+00:00"
generated_at: "2026-06-20T21:48:30.522211+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.35
calibrated_materiality_score: 0.35
confidence: "high"
source: SEC EDGAR
---

# Director John E. Lynch passes away; Jim Moran appointed to Audit and Compensation Committees

## Summary
- John E. Lynch, director since Jan 11, 2021, passed away on Dec 24, 2022.
- Former Congressman Jim Moran (director since Jan 18, 2022) appointed to Audit and Compensation Committees effective Dec 27.
- Richard Prins remains Chairman of Board, Audit and Compensation Committees, and Audit financial expert.
- Board continues with three independent directors: Prins, Moran, and one unnamed.

## SEC filing metadata
- accession: 0001185185-22-001458
- form_type: 8-K
- ticker: IGC
- cik: 0001326205
- company_name: IGC Pharma, Inc.
- filed_at: 2022-12-29T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.35
- calibrated_materiality_score: 0.35
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1326205/000118518522001458/0001185185-22-001458-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1326205/000118518522001458/indiaglob20221228_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001185185-22-001458
- JSON: https://secwatch.observer/filing/0001185185-22-001458.json
- Plain text: https://secwatch.observer/filing/0001185185-22-001458.txt

## Key facts
- Executive change
  John E. Lynch departed as Director at IGC Pharma, Inc..
  - Action: passed away
  - Role: Director
  source text: On December 24, 2022, John E. Lynch, a Director of India Globalization Capital Inc. (the “Company” or “IGC”), passed away.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1326205/000118518522001458/0001185185-22-001458-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.